Product ID: SQMIG35H2246
Report ID:
SQMIG35H2246 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
90 |
Figures:
76
Global 3D Cell Culture Market size was valued at USD 1.3 billion in 2022 and is poised to grow from USD 1.31 billion in 2023 to USD 11.79 billion by 2031, growing at a CAGR of 18.2% during the forecast period (2024-2031).
3D system electronics have emerged as the basis for drug research, preclinical testing, tissue engineering, and basic sciences, due to their improvement over the traditional technologies. As the cells in the 3D cell culture are allowed to grow and interact in 3D dimensions, the cells can engage with the extracellular matrix which in turn improves the physiological relevance of the cells. While the conventional 2D cultures manage the cells in a flat monolayer, the 3D cultures resemble better the differentiated structures found in vivo. This diversity of 3D cell models includes 3D spheroids, organoids, bioprinted cell models, and organs-on-chips.
The spheroids develop from the cellular growth and aggregation within the 3D culture, possessing a spherical shape as well as maintaining the original cell's genetic composition. Organoids that are produced from stem cells or progenitor cells possess more mature function and a greater degree of complexity. The organs-on-chips that are microfluidic devices are the ones that are structurally like the organs cells and fluid is flowing dynamically in them.
The fast-escalating chronic diseases and medical conditions like multiple organ failures are the major factors behind the high number for organ transplantation. Nevertheless, the scarcity in donors has sparked the exploration for other ways which including regenerative medicine and tissue engineering. 3D cell culture systems are thus enhancing organoid culture and functional tissue constructs development in this way to be later used in tissue transplant and drug response analysis.
In addition, based on the development of new products that are designed to improving the tissue culture and tissue engineering, there is a market is witnessing the introduction of new products. For instance, In June 2023, 3D BioFibR launched two innovative 3D bioprinting collagen fiber products (CollaFibR 3D scaffold and μCollaFibR) in the 3D cell culture capabilities improved. Moreover, a strong demand for in-vitro testing models across various end-user segments, coupled with numerous organic and inorganic initiatives by market participants, is expected to drive market growth.
For Instance, in December 2023, Charles River Laboratories disclosed their partnership with CELLphenomics, aiming to broaden their 3D in vitro services for drug screening applications in cancer therapy.
US 3D Cell Culture Market is poised to grow at a sustainable CAGR for the next forecast year.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35H2246